Cirrhosis alcoholic and drugs of ingredients of amiodarone hydrochloride - a phase IV clinical study of FDA data
Cirrhosis alcoholic is reported only by a few people who take drugs with ingredients of amiodarone hydrochloride. This phase IV clinical study analyzes 86,013 people who have side effects while taking drugs with ingredients of amiodarone hydrochloride from the the FDA. Among them, 5 have Cirrhosis alcoholic. Find out below who they are, when they have Cirrhosis alcoholic and more.
Drug(s) considered in the study (i.e. both brand name and generic drugs): Amiodarone hydrochloride, Cordarone, Nexterone, Pacerone.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
86,013 people reported to have side effects when taking drugs with ingredients of amiodarone hydrochloride.
Among them, 5 people (0.01%) have Cirrhosis alcoholic
What is Cirrhosis alcoholic?
Cirrhosis alcoholic (chronic disease of the liver marked by degeneration of cells, inflammation, and fibrous thickening of tissue caused by alcoholism) is found to be associated with 363 drugs and 162 conditions by eHealthMe.
Number of reports submitted per year:
Gender of people who have Cirrhosis alcoholic when taking drugs with ingredients of amiodarone hydrochloride *:
- female: 75 %
- male: 25 %
Age of people who have Cirrhosis alcoholic when taking drugs with ingredients of amiodarone hydrochloride *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
Conditions people have *:
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 60.00%
- Cardiac Failure: 1 person, 20.00%
- Bleeding Disorders: 1 person, 20.00%
Other drugs people take *:
- Ventolin: 3 people, 60.00%
- Spiriva: 3 people, 60.00%
- Pantoprazole: 3 people, 60.00%
- Lasix: 3 people, 60.00%
- Vitamin D: 2 people, 40.00%
- Metformin: 1 person, 20.00%
- Entresto: 1 person, 20.00%
- Eliquis: 1 person, 20.00%
Other side effects people have besides Cirrhosis alcoholic *:
- Sick Sinus Syndrome (a collection of heart rhythm disorders): 4 people, 80.00%
- Overdose: 4 people, 80.00%
- Non-Alcoholic Steatohepatitis (liver inflammation caused by a build up of fat in the liver): 4 people, 80.00%
- Hypophagia (reduced food intake): 4 people, 80.00%
- Cardiac Failure: 3 people, 60.00%
- Pulmonary Hypertension (increase in blood pressure in the lung artery): 3 people, 60.00%
- Weakness: 1 person, 20.00%
- Hepatic Failure (liver failure): 1 person, 20.00%
- Breathing Difficulty: 1 person, 20.00%
- Diarrhea: 1 person, 20.00%
* Approximation only. Some reports may have incomplete information.
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Tesic D, Kostic M, Paunovic D, Jankovic SM, "Analysis of the cost–effectiveness of dronedarone versus amiodarone, propafenone, and sotalol in patients with atrial fibrillation: results for Serbia", Kardiologia Polska (Polish Heart Journal), 2016 Jan .
- Kim DJ, Lee SC, Park GS, Kim GJ, Hwang WT, Lee CS, Lee MH, Hahn DH, Koh HC, "Amiodarone Induced Multiorgan Toxicity in a Patient of Hypertrophic Cardiomyopathy With Atrial Fibrillation", Journal of the Korean Geriatrics Society, 2013 Dec .
Drugs with ingredients of amiodarone hydrochloride, their effectiveness, alternatives and more:
How the study uses the data?
The study uses data from the FDA. It is based on amiodarone hydrochloride. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Skyla vs. Folic Acid - 3 seconds ago
- Blast Crisis In Myelogenous Leukaemia and Leukopenia - 7 seconds ago
- Blast Crisis In Myelogenous Leukaemia and Leukaemia Recurrent - 9 seconds ago
- Blast Crisis In Myelogenous Leukaemia and Leukocytosis - 13 seconds ago
- Tyvaso and Cheilitis - 16 seconds ago
- Deca-Durabolin and Nausea - 16 seconds ago
- Sulfacetamide Sodium and Centrum drug interaction - 27 seconds ago
- Lamivudine and Listeriosis - 34 seconds ago
- Solu-Medrol and Diabetic Nephropathy - 34 seconds ago
- Zestril and Eye Haemorrhage - 35 seconds ago